Support LinkSM is a new online hub that gives you tools and resources to make an informed decision about deep brain stimulation (DBS) as a treatment option. It consists of six tools aimed at helping anyone considering Parkinson’s DBS therapy.
Support LinkSM provides comprehensive, professional information on DBS therapy. It can help you to better understand the benefits and risks of the therapy, and when to consider it.
Each Support LinkSM tool provides up-to-date information on DBS therapy. Here’s a quick guide:
In this animated introduction to the basics of DBS, ‘Emily ‘shares her experience of the procedure and how she felt about it. Shortly you will also have the opportunity to attend live webinars where experts explain DBS therapy in details.
2. Physician finder
If you aren’t getting the symptom relief you need from medication, the online physician directory helps you find a movement disorder neurologist or an expert DBS centre near you.
3. DBS referral adviser
Are you considering DBS therapy but don’t know if you are a good candidate? The DBS referral adviser tool is an online questionnaire that will make it easy to decide if DBS is a therapy you may want to discuss with your doctor. It will also help you to get ready for your next doctor’s appointment.
Your answers to the simple questionnaire – which you can complete at home – generate a report that you can then print and take to your next appointment. The report will help your doctor to understand how Parkinson’s affects you and how your current treatment plan is working. This tool has been developed and validated by experts such as neurologists, people with Parkinson’s and their families, and nurses.
4. Ambassador programme
Are you unsure how DBS therapy will affect you? With the ambassador programme, you can talk to someone who has experienced DBS therapy before. Ambassadors are volunteers – they are not medical experts or Medtronic employees. They are people who are happy to talk with you on the phone about their DBS experiences. You can also ask questions such as, “What was the procedure like?” and “How has it impacted on your daily life?” etc.
5. Support meetings
This is a list of DBS-related events taking place in your country that may support you in your Parkinson’s journey.
6. EPDA’S PD info
The EPDA owns the largest online library dedicated to Parkinson’s disease in Europe, packed with wide-ranging information on every aspect of the condition that will supplement your decision on DBS and any other Parkinson’s-related queries.
Video: introduction to Support LinkSM
How to access Support LinkSM
Visit either the EPDA website or the Medtronic UK website to access all these tools and resources*. Local Parkinson’s associations and/or patient groups are encouraged to provide Support LinkSM to their members. The tools can be translated and added to your own website. Your regional Medtronic team is there to support you with IT implementation, translation as well as recruiting Ambassadors.
* Support LinkSM is currently available in the UK, but will soon be coming to other European countries.
Deep brain stimulation – one of Medtronic’s neuromodulation therapies – has been transforming the lives of people with movement disorders for over 25 years. Together with Professor Alim Louis Benabid and Professor Pierre Pollak, Medtronic pioneered DBS therapy and today over 125,000 people have benefited from this therapy worldwide.
The information contained on Support LinkSM is designed to help people with Parkinson’s learn more about the therapy and to provide them with helpful information. It is meant for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis or treatment in any manner. This therapy may not work for everyone. Results may vary from patients to patients. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For further information, please consult your healthcare professional who can explain the benefits & risks and important safety information.
How the drug-addicted William Burroughs inspired a world-renowned Parkinson’s professor
Mentored by a Madman: an exclusive review of Dr Andrew Lees' new book
2 days ago
Heart problems linked to dementia risk in Parkinson’s disease, say researchers
Researchers at the University of Turin, Italy, have identified that Parkinson’s-related cardiovascular problems may increase a patient’s risk of developing dementia within five years. According to the study, it is estimated that more than half of people with Parkinson’s experience an impairment of the autonomic nervous system – which helps to regulate bodily functions such as blood pressure, body temperature, respiration and heart rate. The researchers investigated the effects of this impairment on key functional Parkinson’s outcomes – including dementia, falls and postural instability – by observing 65 patients at the university’s movement disorders centre and following up after five years. Evaluations throughout the study assessed patients’ cognitive function, automatic symptoms and other motor and non-motor features. In the findings, which were published in the ‘Journal of Neurology’, the researchers noted that worse cardiovascular assessment scores were “associated with a sevenfold higher risk of developing dementia”.
A “revolutionary” step in stem cell therapy for Parkinson’s disease?
Scientists in China have developed a method to help improve stem cell research in mice models of Parkinson’s – which could potentially lead to promising new treatments. The researchers, based at the Chinese Academy of Sciences, identified two cell surface markers of dopamine neurons, which are reduced in Parkinson’s. They injected cells with these markers into the brains of the mice and found that this resulted in “higher therapeutic potency” for improving motor symptoms of the condition. As part of their research, the team also worked to control the variability of donor cells, to help improve therapeutic outcomes for Parkinson’s cell therapy. The researchers, whose study was published in ‘The Journal of Clinical Investigation’, described the findings as a “revolutionary step on the road towards more effective and safer stem cell therapies”.
Could frequent nightmares be an early sign of Parkinson’s disease?
A new study has suggested that experiencing recurrent nightmares and bad dreams could be an early symptom of Parkinson’s disease. Researchers from the University of Birmingham, UK, used data from an existing US study that followed 3818 men, aged 67 or older, over a period of 12 years. Participants who reported experiencing bad dreams at least once a week were followed up. During the follow up, 91 people were diagnosed with Parkinson’s. The results suggested that participants who had frequent bad dreams were twice as likely to develop the condition as those who did not. Commenting on the study, lead author Dr Abidemi Otaiku said: “While we need to carry out further research, identifying the significance of bad dreams and nightmares could indicate that individuals who experience changes to their dreams in older age – without any obvious trigger – should seek medical advice.”